SOTROVIMAB

(Emergency Use Authorization)

 

Important Update: Sotrovimab is currently not authorized in any US region, due to the prevalence of SARS-CoV-2 Omicron BA.2 sub-variant, until further notice by the FDA. FDA's statement and any updates on the authorization will be available on the FDA website.